"From the wound dressing trial there doesn`t seem to be any foam offering by KCI that can`t be replaced by Polynovo..." But it looks like KCI are now looking in an entirely different direction.
KCI throwing $485 million at Systagenix doesn't bode well for a deal with Polynovo. It looks like KCI have hitched their wagon to another horse. I think KCI would rather take over than license.
What I fail to understand it the infatuation with collagen scaffolds.
CZD Price at posting:
8.7¢ Sentiment: Buy Disclosure: Held
